Showing 1021-1030 of 1148 results for "".
- New Resources Available at MoreThanMemoryLoss.com--Launched Today in Honor of National Caregivers Dayhttps://practicalneurology.com/news/new-resources-available-at-morethanmemorylosscom-launched-today-in-honor-of-national-caregivers-day/2469503/In honor of National Caregiver's Day, a new educational website and resource center, MoreThanMemoryLoss.com, has launched. The site is designed for caregivers of people who are living with dementia-related hallucinations and delusi
- Social Isolation Increases the Risk of Heart Attacks, Strokes, and Deathhttps://practicalneurology.com/news/social-isolation-increases-the-risk-of-heart-attacks-strokes-and-death/2469272/A German study, the Heinz Nixdorf Recall study (HNR) presented at the European Academy of Neurology (EAN) Virtual Congress found that people who are socially isolated are almost 50% more likely to die from any cause. It was also found that a lack of financial support independently increased the r
- Young Black and Latino People May Fare Better Than Whites After Hemorrhagic Strokehttps://practicalneurology.com/news/young-black-and-latino-people-may-fare-better-than-whites-after-hemorrhagic-stroke/2469136/Young black and Latino people may be less likely than young white people to be disabled or even die within 3 months of a hemorrhagic stroke. This is reported in a clinical study published in Neurology, which focused on younger people who have had hemorrhagic stroke. Of whites in the stu
- AHA Promotes Secondary Stroke Prevention as Crucial During COVID-19 Pandemichttps://practicalneurology.com/news/aha-promotes-secondary-stroke-prevention-as-crucial-during-covid-19-pandemic/2469197/As hospitals, healthcare systems, and healthcare providers strive to reduce the spread of coronavirus, the American Heart Association (AHA) offers tips for heart attack and stroke survivors for secondary prevention during this difficult time. Based on current information about the
- Making Travel Less Stressful for People With Migrainehttps://practicalneurology.com/news/making-travel-less-stressful-for-people-with-migraine/2469912/A survey conducted by Condé Nast Traveler explores the impact of migraine on people's plans to travel whether for work or vacations. The 500 survey respondents all had a self-reported physician-made diagnosis of migraine. Almost all respondents (94%) found the thought o
- Treatment of Refractory Status Epilepticus Prevents Need for Induced Coma With Intravenous Anesthetics in Phase 2 Trialhttps://practicalneurology.com/news/treatment-of-refractory-status-epilepticus-prevents-need-for-induced-coma-with-intravenous-anesthetics-in-phase-2-trial/2469053/In a phase 2 clinical trial, treatment with ganaxolone prevented all 17 participants from needing IV anesthetics for induced coma within 24 hours of treatment initiation. All participants had ganaxolone after status epilepticus continued despite treatment with benzodiazpeines. A target dose
- Treatment with Briumvi Improves Fatigue in Patients with Relapsing Multiple Sclerosishttps://practicalneurology.com/news/treatment-with-briumvi-improves-fatigue-in-patients-with-relapsing-multiple-sclerosis/2470196/Post hoc analyses of the phase 3 ULTIMATE I and II (NCT03277261 and NCT03277248) trials showed a significant reduction from baseline Fatigue Impact Scale (FIS) total score at all time points for participants with relapsing
- Atuzaginstat Slows Cognitive Decline in P. Gingivalis-Positive Participantshttps://practicalneurology.com/news/atuzaginstat-slows-cognitive-decline-in-p-gingivalis-positive-participants/2469730/In the phase 2/3 GAIN trial (NCT03823404), across all participants (n=643) with mild to moderate Alzheimer disease (AD) treated with atuzaginstat (COR338; Cortexyme, South San Francisco, CA), no s
- Clinical Trial of Nanocrystalline Gold for Amyotrophic Lateral Sclerosis Completes Double-Blinded Phasehttps://practicalneurology.com/news/clinical-trial-of-nanocrystalline-gold-for-amyotrophic-lateral-sclerosis-completes-double-blinded-phase/2469688/All patient visits have been completed in the phase 2 study (NCT04098406) of catalytically active gold nanocrystals (Clene Nanomedicine, Salt Lake City, UT) for early-stage amyotrophic lateral scl
- Mixed Sodium Oxybates Improve Idiopathic Hypersomniahttps://practicalneurology.com/news/mixed-sodium-oxybates-improve-idiopathic-hypersomnia/2469574/In a phase 3 study (NCT03533114) of mixed salt oxybates (MSO) (Xywav; Jazz Pharmaceuticals, Philadelphia, PA) for treatment of idiopathic hypersomnia (IH) showed improvement on multiple measures. All participants first received tr